Related Experiment Video
Updated: Oct 6, 2026

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure
Published on: January 18, 2021
EVIDENCE-BASED PHARMACOTHERAPY FOR ANXIETY DISORDERS COMORBID WITH PTSD: A SYSTEMATIC REVIEW
L Bashkirova1, I Romanova2, V Yatsynovych3
11Department of Neurology, Educational and Scientific Institute of Professional Excellence, Shupyk National Healthcare University of Ukraine, Kyiv, Ukraine.
Objective:
To evaluate the efficacy, safety, and tolerability of pharmacological interventions for anxiety outcomes in adults with post-traumatic stress disorder (PTSD), including confirmed comorbid anxiety disorders and clinically significant anxiety symptoms.
Material And Methods:
PubMed/MEDLINE, Scopus, Web of Science, PsycINFO, and Cochrane CENTRAL were searched for randomized controlled trials and prospective cohort studies published from 2000 to 2025. Risk of bias was assessed with Cochrane tools, and certainty of evidence with GRADE.
Results:
Twenty-two studies involving 2,708 participants were included. Selective serotonin reuptake inhibitors (SSRIs) reduced anxiety symptoms (standardized mean difference [SMD] -0.46; 95% confidence interval [CI] -0.62 to -0.30; moderate certainty) and PTSD symptoms (SMD -0.43; 95% CI -0.58 to -0.28; moderate certainty). However, applicability to formally diagnosed comorbid anxiety disorders was limited by inconsistent diagnostic reporting. Serotonin-norepinephrine reuptake inhibitors (SNRIs) reduced anxiety symptoms (SMD -0.38; 95% CI -0.55 to -0.21; low certainty), whereas evidence for PTSD outcomes was less certain. Atypical antipsychotics showed possible benefit but increased discontinuation due to adverse events (RR 2.14; 95% CI 1.43 to 3.21).
Conclusions:
SSRIs provide moderate-certainty evidence for reducing anxiety outcomes in PTSD populations. Evidence for confirmed comorbid anxiety disorders remains limited. SNRIs and atypical antipsychotics have lower-certainty evidence, and atypical antipsychotics are associated with greater adverse-event discontinuation.
Related Concept Videos
Behavior Therapy
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Generalized Anxiety Disorder
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Anxiety: Overview
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Post-traumatic Stress Disorder
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events, are a...
Drug Therapy
Antianxiety Medications